Zevaskyn Cellular Sheet
Product Images NDC 84103-007

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zevaskyn (NDC 84103-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abeona Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zevaskyn 01)

The available text mentions forceps, Thanium ligating clips, and a sterile field. These indicate the use of medical equipment for surgical procedures in a controlled and sanitized environment. Forceps are commonly used for grasping and holding tissues during surgery, Thanium ligating clips are likely for clamping blood vessels, and a sterile field ensures a clean environment to prevent infection.*

FDA Label Image

Principal Display Panelprademagene Zamikeracelzevaskyngene-modified Cellular Sheetsrx Only (Zevaskyn 02)

This text describes a gene-modified cellular sheets product intended for autologous, topical use only. The product contains up to four sheets of autologous cell-based gene therapy, with each sheet measuring 41.25 cm². It specifies that the product does not contain preservatives and should be stored at room temperature. The product is manufactured and distributed by Abeona Therapeutics Inc. located in Cleveland, OH. Contact information and licensing details are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.